SCHIZO AFFECTIVE DISORDER
Clinical trials for SCHIZO AFFECTIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new SCHIZO AFFECTIVE DISORDER trials appear
Sign up with your email to follow new studies for SCHIZO AFFECTIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an arthritis drug ease tough schizophrenia symptoms?
Disease control Not yet recruitingThis study tests a drug called mirikizumab, which is already approved for other conditions, in people with schizophrenia who have a specific immune marker (AGA IgG antibodies). The goal is to see if it can improve negative symptoms like lack of motivation and pleasure, as well as…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: PHASE4 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a smartphone app improve medication adherence in schizophrenia?
Knowledge-focused Not yet recruitingThis study will test a new mobile mental health app designed to help people with schizophrenia or schizoaffective disorder stick to their medication routine. Researchers will enroll 50 adults who are in remission and see if using the app is practical and well-liked. The goal is t…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: NA • Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Can a clubhouse model sharpen thinking in schizophrenia? new study aims to find out
Knowledge-focused Not yet recruitingThis pilot study will compare the Clubhouse Model—a structured, community-based program where members work together to run the clubhouse—to standard outpatient care for adults with schizophrenia. Researchers will measure changes in thinking, daily functioning, and brain activity …
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: NA • Sponsor: Case Western Reserve University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Cannabis and schizophrenia: a Real-World look at the dual effects
Knowledge-focused Not yet recruitingThis study will follow 120 people with schizophrenia who use cannabis, using mobile phone surveys and thinking tasks to track symptoms in real time. The goal is to understand how cannabis may both worsen positive symptoms (like hallucinations) and reduce negative symptoms (like l…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: PHASE1, PHASE2 • Sponsor: Centre Hospitalier Charles Perrens, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC